tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
CANC
Tema Oncology ETF
Overview
Analyst Forecasts
Holdings
ETF AI Analysis
Dividends
Technical Analysis
Chart
Similar ETFs
Heatmap
research tools
Top ETFs by Upside
Top ETFs by Smart Score
ETF Screener
Compare ETFs
Advertisement

CANC Holdings Information

Compare
Holdings Count
56
Total Assets
115.24M
Top 10 Percentage
42.95%
Asset Class
Equity
Category
Sector
Region
Global
See the full list of holdings, find out what stocks are the most undervalued and get access to the all ETF's smart score and filters.Go Premium
56 Holdings as of Dec 25, 2025
56 Holdings as of Dec 25, 2025
Name
Weight %
Market Value
Price & Change
Market Cap
Yearly Gain
Analyst Consensus
Analyst Price Target
Smart Score
Follow
RVMD
Revolution Medicines, Inc.
6.25%
$7.16M
―
$15.70B
79.27%
20 Buy
0 Hold
0 Sell
Strong Buy
―
LLY
Eli Lilly And Company
5.21%
$5.96M
―
$1.02T
35.62%
18 Buy
2 Hold
0 Sell
Strong Buy
―
AZN
AstraZeneca plc
4.37%
$5.01M
―
£211.99B
31.03%
12 Buy
2 Hold
1 Sell
Moderate Buy
―
BBIO
Bridgebio Pharma
4.36%
$4.99M
―
$14.72B
167.79%
16 Buy
0 Hold
0 Sell
Strong Buy
―
NOVN
Novartis
4.23%
$4.85M
―
CHF209.54B
25.57%
7 Buy
3 Hold
1 Sell
Moderate Buy
―
RHHBY
Roche Holding AG
4.06%
$4.65M
―
$334.11B
50.09%
1 Buy
2 Hold
0 Sell
Moderate Buy
―
GMAB
Genmab (Otc)
3.96%
$4.54M
―
$20.63B
63.85%
5 Buy
2 Hold
0 Sell
Moderate Buy
―
COGT
Cogent Biosciences, Inc.
3.63%
$4.16M
―
$6.04B
404.83%
8 Buy
2 Hold
0 Sell
Strong Buy
―
EXEL
Exelixis
3.46%
$3.96M
―
$12.47B
36.67%
8 Buy
8 Hold
0 Sell
Moderate Buy
―
BMY
Bristol-Myers Squibb Company
3.42%
$3.91M
―
$111.38B
-5.67%
8 Buy
11 Hold
1 Sell
Moderate Buy
―
Rows:
10

Sector Breakdown

99.03%Healthcare0.97%General99.03%Healthcare
Healthcare
99.03%
General
0.97%

Countries Breakdown

89.85%United States4.37%United Kingdom4.23%Switzerland1.54%Japan89.85%United States
United States
89.85%
United Kingdom
4.37%
Switzerland
4.23%
Japan
1.54%

Breakdown By Smart Score

17.26%Outperform1018.42%Outperform919.45%Outperform825.94%Neutral714.32%Neutral61.59%Neutral51.05%Neutral41.66%Underperform30.31%Underperform28
The weighted average smart score of the CANC ETF is 8
10
17.26%
9
18.42%
8
19.45%
7
25.94%
6
14.32%
5
1.59%
4
1.05%
3
1.66%
2
0.31%
1
0.00%

CANC ETF News

GLP-1 Pills Gain Ground: Novo Nordisk Wins FDA Nod as Food Giants Tweak Strategy
PremiumMarket News

GLP-1 Pills Gain Ground: Novo Nordisk Wins FDA Nod as Food Giants Tweak Strategy

2d ago
CAG
CMG
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
PremiumMarket News

Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?

2d ago
LLY
NVO
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Extending Long-Term Upside Potential
PremiumCompany Announcements

Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Extending Long-Term Upside Potential

2d ago
RVMD
Eli Lilly (LLY) a Top Stock Split Candidate in 2026
PremiumMarket News

Eli Lilly (LLY) a Top Stock Split Candidate in 2026

2d ago
LLY
AAPL
See More CANC News
See More CANC News

CANC ETF FAQ

What are ETF CANC’s top 3 holdings?
CANC’s top 3 holdings are RVMD, LLY, GB:AZN.
    What is ETF CANC’s holdings count?
    ETF CANC’s is holdings 56 different assets.
      What are the total assets of ETF CANC?
      ETF CANC’s total assets are 115.24M.
        Become an Expert with TipRanks Premium
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing
        Advertisement